Table 1.
Symbol | Gene name | Gene ID | FDR | Ptreatment | Pinteraction |
FC AMNA/IL-1β |
Pairwise |
||||
---|---|---|---|---|---|---|---|---|---|---|---|
FC 1 h | FC 3 h | FC 6 h | 1 h | 3 h | 6 h | ||||||
AAK1 | AP2 associated kinase 1 | 22848 | 9.13e-02 | 5.98e-03 | 7.26e-01 | 1.55 | 1.66 | 1.31 | * | ||
ACAP1 | ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 | 9744 | 1.65e-02 | 2.07e-04 | 4.01e-01 | −1.50 | −1.23 | −1.36 | ** | * | |
AGAP2 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 | 116986 | 1.73e-03 | 8.86e-05 | 4.53e-01 | −1.39 | −1.58 | −1.31 | ** | ** | * |
AK4 | adenylate kinase 4 | 205 | 8.79e-03 | 4.27e-01 | 7.56e-04 | 1.41 | −1.01 | −1.64 | * | ** | |
ANKRD1 | ankyrin repeat domain 1 (cardiac muscle) | 27063 | 8.02e-03 | 2.75e-02 | 1.23e-02 | 1.26 | −1.46 | −1.78 | * | ** | |
ANKRD13A | ankyrin repeat domain 13A | 88455 | 8.98e-02 | 2.37e-04 | 1.88e-01 | 1.23 | 1.47 | 1.18 | * | ** | |
ANXA3 | annexin A3 | 306 | 4.39e-04 | 7.76e-02 | 7.05e-04 | 1.48 | −1.33 | −1.70 | ** | * | ** |
AREG | amphiregulin | 374 | 7.88e-02 | 6.01e-03 | 6.32e-01 | −1.37 | −1.39 | −1.78 | * | ||
ARHGEF26 | Rho guanine nucleotide exchange factor (GEF) 26 | 26084 | 7.10e-02 | 1.36e-03 | 9.35e-01 | 1.42 | 1.33 | 1.42 | * | * | |
ARL4C | ADP-ribosylation factor-like 4C | 10123 | 2.31e-02 | 2.22e-04 | 8.41e-01 | −1.41 | −1.30 | −1.39 | ** | ** | |
ATF7IP2 | activating transcription factor 7 interacting protein 2 | 80063 | 5.87e-02 | 5.59e-03 | 1.69e-01 | 1.77 | 1.17 | 1.22 | ** | ||
BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 10018 | 8.59e-04 | 7.06e-05 | 3.23e-02 | 1.60 | 1.48 | 1.09 | ** | ** | * |
BCL3 | B-cell CLL/lymphoma 3 | 602 | 4.12e-03 | 3.18e-02 | 5.00e-03 | −1.98 | −1.05 | 1.13 | ** | ||
BMP6 | bone morphogenetic protein 6 | 654 | 1.78e-02 | 3.25e-03 | 6.12e-02 | −1.00 | 1.65 | 1.47 | ** | * | |
BNIP3 | BCL2/adenovirus E1B 19 kDa interacting protein 3 | 664 | 0.00e+00 | 3.64e-05 | 4.09e-06 | 1.11 | −1.12 | −2.54 | ** | ||
BRCA1 | breast cancer 1, early onset | 672 | 7.46e-02 | 4.42e-01 | 1.64e-02 | 1.96 | −1.28 | −1.15 | ** | ||
BUB1 | BUB1 mitotic checkpoint serine/threonine kinase | 699 | 1.40e-02 | 5.76e-01 | 5.38e-03 | 1.93 | −1.28 | −1.26 | ** | ||
BUB1B | BUB1 mitotic checkpoint serine/threonine kinase B | 701 | 5.11e-02 | 4.12e-01 | 1.69e-02 | 2.09 | −1.32 | −1.14 | ** | ||
C14orf105 | chromosome 14 open reading frame 105 | 55195 | 6.13e-02 | 4.75e-03 | 5.28e-01 | −1.22 | −1.59 | −1.62 | * | * | |
C15orf48 | chromosome 15 open reading frame 48 | 84419 | 5.83e-03 | 7.16e-05 | 4.51e-02 | −1.61 | −1.17 | −1.25 | ** | * | |
C1orf63 | chromosome 1 open reading frame 63 | 57035 | 3.07e-03 | 1.82e-04 | 3.43e-01 | 1.61 | 1.27 | 1.38 | ** | * | |
C2orf44 | chromosome 2 open reading frame 44 | 80304 | 9.87e-03 | 1.63e-03 | 2.02e-01 | 1.79 | 1.35 | 1.20 | ** | ||
C3orf58 | chromosome 3 open reading frame 58 | 205428 | 1.08e-05 | 3.22e-01 | 1.35e-06 | 1.54 | 1.17 | −1.61 | ** | * | ** |
C7orf53 | chromosome 7 open reading frame 53 | 286006 | 6.37e-05 | 1.06e-03 | 1.05e-02 | 2.19 | 1.05 | 1.27 | ** | ||
C9orf131 | chromosome 9 open reading frame 131 | 138724 | 9.82e-03 | 4.39e-04 | 7.67e-02 | 1.67 | 1.21 | 1.19 | ** | ||
CACHD1 | cache domain containing 1 | 57685 | 4.66e-02 | 2.02e-03 | 4.84e-01 | 1.31 | 1.63 | 1.29 | ** | ||
CBLB | Cbl proto-oncogene, E3 ubiquitin protein ligase B | 868 | 8.71e-02 | 1.29e-02 | 2.19e-01 | 1.07 | 1.86 | 1.45 | * | ||
CCL22 | chemokine (C–C motif) ligand 22 | 6367 | 0.00e+00 | 6.98e-06 | 6.53e-02 | −1.36 | −2.20 | −1.99 | * | ** | ** |
CD70 | CD70 molecule | 970 | 9.39e-02 | 1.09e-03 | 2.37e-01 | −1.53 | −1.22 | −1.20 | ** | ||
CD83 | CD83 molecule | 9308 | 1.63e-03 | 4.10e-04 | 8.35e-02 | 1.80 | 1.22 | 1.27 | ** | ||
CEBPD | CCAAT/enhancer binding protein (C/EBP), delta | 1052 | 6.06e-03 | 4.58e-01 | 6.34e-04 | −1.70 | 1.12 | 1.31 | ** | * | |
CENPF | centromere protein F, 350/400 kDa | 1063 | 8.68e-02 | 6.92e-01 | 2.45e-02 | 1.90 | −1.75 | −1.31 | * | ||
CEP55 | centrosomal protein 55 kDa | 55165 | 4.42e-02 | 7.14e-01 | 8.10e-03 | 1.68 | −1.40 | −1.35 | * | ||
CEP76 | centrosomal protein 76 kDa | 79959 | 7.67e-02 | 2.29e-03 | 1.52e-01 | 1.57 | 1.32 | 1.09 | ** | * | |
CHCHD7 | coiled-coil-helix-coiled-coil-helix domain containing 7 | 79145 | 6.62e-02 | 3.19e-03 | 4.05e-01 | 1.58 | 1.47 | 1.17 | * | * | |
CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 10370 | 7.93e-02 | 2.38e-01 | 3.69e-03 | −1.38 | 1.47 | 1.22 | * | ** | |
CKAP2L | cytoskeleton associated protein 2-like | 150468 | 1.53e-02 | 1.45e-01 | 1.89e-02 | 1.57 | −1.97 | −1.57 | * | ||
CLEC4E | C-type lectin domain family 4, member E | 26253 | 4.03e-03 | 8.42e-04 | 3.66e-01 | −1.25 | −1.53 | −1.71 | * | ** | |
CNNM4 | cyclin M4 | 26504 | 1.79e-07 | 9.46e-05 | 4.77e-04 | −1.11 | 2.00 | 1.57 | ** | ** | |
CSF2 | colony stimulating factor 2 (granulocyte-macrophage) | 1437 | 1.02e-03 | 8.79e-04 | 7.21e-01 | −1.68 | −1.88 | −1.48 | * | ** | |
CTH | cystathionase (cystathionine gamma-lyase) | 1491 | 6.66e-03 | 1.90e-04 | 3.46e-01 | 1.29 | 1.59 | 1.31 | * | ** | * |
CTSK | cathepsin K | 1513 | 2.91e-03 | 4.28e-04 | 9.47e-01 | 1.54 | 1.53 | 1.45 | * | * | * |
CUZD1 | CUB and zona pellucida-like domains 1 | 50624 | 7.05e-02 | 3.72e-02 | 4.52e-02 | 1.95 | 1.02 | 1.05 | ** | ||
CX3CL1 | chemokine (C-X3-C motif) ligand 1 | 6376 | 1.25e-02 | 3.11e-03 | 4.58e-01 | −1.94 | −1.48 | −1.33 | ** | ||
CXCL3 | chemokine (C-X-C motif) ligand 3 | 2921 | 8.34e-02 | 1.65e-02 | 5.71e-02 | −1.70 | −1.34 | 1.07 | ** | ||
CXCL6 | chemokine (C-X-C motif) ligand 6 | 6372 | 2.85e-03 | 1.69e-04 | 6.11e-01 | −1.39 | −1.34 | −1.58 | * | * | ** |
CYB5D1 | cytochrome b5 domain containing 1 | 124637 | 2.40e-03 | 1.21e-03 | 7.39e-02 | 1.78 | 1.50 | 1.07 | ** | * | |
CYP24A1 | cytochrome P450, family 24, subfamily A, polypeptide 1 | 1591 | 2.62e-05 | 4.54e-05 | 7.89e-01 | −1.52 | −1.69 | −1.51 | ** | ** | ** |
DBR1 | debranching enzyme homolog 1 (Saccharomyces cerevisiae) | 51163 | 7.97e-02 | 1.06e-03 | 4.21e-01 | 1.52 | 1.26 | 1.24 | ** | ||
DDIT4 | DNA-damage-inducible transcript 4 | 54541 | 5.57e-04 | 5.87e-04 | 5.05e-01 | −1.90 | −1.40 | −1.57 | ** | * | |
DDR1 | discoidin domain receptor tyrosine kinase 1 | 780 | 1.43e-02 | 1.48e-03 | 8.30e-02 | −1.73 | −1.26 | −1.13 | ** | ||
DENND2C | DENN/MADD domain containing 2C | 163259 | 3.14e-02 | 1.33e-03 | 9.57e-01 | 1.44 | 1.49 | 1.40 | * | * | * |
DEPDC1 | DEP domain containing 1 | 55635 | 5.44e-02 | 9.05e-01 | 1.02e-02 | 1.75 | −1.26 | −1.44 | * | ||
DKK1 | dickkopf 1 homolog (Xenopus laevis) | 22943 | 2.94e-05 | 5.83e-05 | 1.71e-02 | −1.25 | −1.25 | −1.94 | ** | ||
DLEU1 | deleted in lymphocytic leukemia 1 (non-protein coding) | 10301 | 7.23e-02 | 5.02e-03 | 1.27e-01 | 1.71 | 1.19 | 1.14 | ** | ||
DLGAP5 | discs, large (Drosophila) homolog-associated protein 5 | 9787 | 4.29e-03 | 1.58e-01 | 2.80e-03 | 1.51 | −1.58 | −1.42 | * | * | * |
DNAJB1 | DnaJ (Hsp40) homolog, subfamily B, member 1 | 3337 | 1.36e-02 | 4.99e-03 | 4.35e-02 | 1.82 | 1.31 | 1.00 | ** | ||
DUSP8 | dual specificity phosphatase 8 | 1850 | 5.16e-03 | 1.05e-02 | 4.26e-03 | −1.87 | 1.06 | −1.07 | ** | ||
EBI3 | Epstein-Barr virus induced 3 | 10148 | 0.00e+00 | 6.30e-06 | 6.87e-01 | −1.82 | −1.73 | −2.06 | ** | ** | ** |
ECT2 | epithelial cell transforming sequence 2 oncogene | 1894 | 6.84e-03 | 5.43e-02 | 1.07e-02 | 1.36 | −1.84 | −1.45 | ** | ||
EDN1 | endothelin 1 | 1906 | 0.00e+00 | 2.33e-06 | 8.60e-01 | −1.79 | −1.93 | −1.97 | ** | ** | ** |
EFNA1 | ephrin-A1 | 1942 | 4.91e-03 | 1.20e-03 | 2.03e-02 | −1.74 | −1.02 | −1.31 | ** | * | |
EFNB2 | ephrin-B2 | 1948 | 1.76e-02 | 3.27e-03 | 1.81e-01 | 1.81 | 1.40 | 1.13 | ** | ||
EGR2 | early growth response 2 | 1959 | 7.52e-03 | 3.57e-03 | 6.43e-03 | −1.80 | −1.04 | −1.06 | ** | ||
EIF4B | eukaryotic translation initiation factor 4B | 1975 | 3.63e-02 | 4.03e-01 | 9.48e-03 | 1.56 | −1.22 | −1.69 | * | * | |
EIF4EBP2 | eukaryotic translation initiation factor 4E binding protein 2 | 1979 | 3.09e-04 | 5.53e-06 | 1.55e-01 | 1.25 | 1.56 | 1.42 | * | ** | ** |
ELF3 | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) | 1999 | 6.05e-02 | 3.62e-02 | 8.45e-03 | −1.24 | 1.43 | 1.43 | * | * | |
ELMSAN1 | ELM2 and Myb/SANT-like domain containing 1 | 91748 | 3.96e-05 | 1.34e-02 | 1.00e-05 | −1.86 | 1.19 | 1.08 | ** | * | |
ELOVL4 | ELOVL fatty acid elongase 4 | 6785 | 8.64e-03 | 5.29e-04 | 3.98e-01 | 1.40 | 1.62 | 1.25 | * | ** | |
ELOVL6 | ELOVL fatty acid elongase 6 | 79071 | 7.35e-02 | 1.86e-01 | 1.29e-02 | 1.84 | −1.08 | −1.15 | ** | ||
ENO2 | enolase 2 (gamma, neuronal) | 2026 | 6.53e-05 | 1.50e-03 | 1.22e-02 | −1.27 | −1.06 | −2.31 | ** | ||
ERCC6L | excision repair cross-complementing rodent repair deficiency, complementation group 6-like | 54821 | 6.72e-02 | 8.17e-01 | 1.39e-02 | 1.75 | −1.58 | −1.21 | * | ||
ERF | Ets2 repressor factor | 2077 | 1.91e-02 | 4.84e-04 | 1.05e-01 | −1.62 | −1.22 | −1.19 | ** | ||
EVA1A | eva-1 homolog A (Caenorhabditis elegans) | 84141 | 1.25e-06 | 3.14e-07 | 4.49e-03 | −1.19 | −1.47 | −1.74 | * | ** | ** |
FAM102A | family with sequence similarity 102, member A | 399665 | 3.29e-02 | 6.69e-02 | 5.48e-03 | −1.32 | 1.41 | 1.48 | * | * | |
FAM111B | family with sequence similarity 111, member B | 374393 | 7.05e-02 | 5.89e-01 | 2.31e-02 | 2.18 | −1.58 | −1.06 | * | ||
FAM46C | family with sequence similarity 46, member C | 54855 | 5.99e-04 | 5.82e-04 | 4.90e-03 | 1.87 | 1.20 | 1.03 | ** | ||
FAM72D | family with sequence similarity 72, member D | 728833 | 2.54e-04 | 4.65e-01 | 1.25e-03 | 1.86 | −1.60 | −1.46 | ** | * | * |
FBLIM1 | filamin binding LIM protein 1 | 54751 | 1.21e-03 | 1.31e-04 | 5.98e-01 | −1.61 | −1.38 | −1.39 | ** | * | * |
FBXL20 | F-box and leucine-rich repeat protein 20 | 84961 | 1.87e-04 | 2.46e-04 | 6.47e-02 | 1.19 | 1.91 | 1.40 | ** | * | |
FBXO33 | F-box protein 33 | 254170 | 4.21e-02 | 9.72e-04 | 7.70e-02 | 1.22 | 1.62 | 1.13 | ** | ||
FLJ36840 | uncharacterized LOC645524 | 645524 | 2.12e-02 | 1.52e-01 | 2.64e-02 | 2.66 | −1.34 | 1.09 | ** | ||
FOS | FBJ murine osteosarcoma viral oncogene homolog | 2353 | 4.65e-06 | 4.26e-04 | 3.84e-04 | 2.13 | 1.01 | 1.08 | ** | ||
FRMD6 | FERM domain containing 6 | 122786 | 4.02e-02 | 1.16e-02 | 3.29e-02 | 1.11 | −1.49 | −1.57 | * | ** | |
FRMD8 | FERM domain containing 8 | 83786 | 3.02e-02 | 6.15e-03 | 2.25e-02 | −1.72 | −1.23 | 1.03 | ** | ||
FST | follistatin | 10468 | 7.49e-02 | 1.12e-03 | 1.27e-01 | −1.07 | −1.44 | −1.42 | ** | ** | |
FUT11 | fucosyltransferase 11 (alpha (1,3) fucosyltransferase) | 170384 | 5.23e-02 | 1.79e-03 | 6.02e-03 | −1.14 | 1.00 | −1.62 | ** | ||
GAN | gigaxonin | 8139 | 4.82e-02 | 6.57e-03 | 1.16e-01 | 1.80 | 1.22 | 1.12 | ** | ||
GAREM | GRB2 associated, regulator of MAPK1 | 64762 | 9.44e-02 | 1.61e-03 | 1.88e-02 | −1.00 | 1.54 | 1.23 | ** | * | |
GAS2L3 | growth arrest-specific 2 like 3 | 283431 | 5.77e-02 | 2.78e-01 | 1.30e-02 | 1.92 | −1.14 | −1.17 | ** | ||
GCLC | glutamate-cysteine ligase, catalytic subunit | 2729 | 3.29e-02 | 2.08e-03 | 7.58e-01 | 1.56 | 1.53 | 1.32 | * | * | |
GCLM | glutamate–cysteine ligase, modifier subunit | 2730 | 1.37e-02 | 1.51e-03 | 5.69e-01 | 1.71 | 1.40 | 1.35 | ** | ||
GLCCI1 | glucocorticoid induced transcript 1 | 113263 | 2.69e-02 | 1.03e-04 | 8.16e-01 | 1.37 | 1.38 | 1.28 | ** | ** | |
GPR56 | G protein-coupled receptor 56 | 9289 | 1.49e-02 | 3.94e-03 | 7.47e-02 | −1.85 | −1.09 | −1.27 | ** | ||
GPR89A | G protein-coupled receptor 89A | 653519 | 5.78e-02 | 3.12e-03 | 3.52e-01 | 1.67 | 1.32 | 1.22 | ** | ||
GRB7 | growth factor receptor-bound protein 7 | 2886 | 1.09e-02 | 1.07e-03 | 5.88e-02 | −1.74 | −1.18 | −1.18 | ** | ||
GTF2B | general transcription factor IIB | 2959 | 6.15e-04 | 8.75e-05 | 1.99e-01 | 1.69 | 1.35 | 1.29 | ** | * | * |
HCAR1 | hydroxycarboxylic acid receptor 1 | 27198 | 9.99e-02 | 3.02e-03 | 7.95e-01 | −1.29 | −1.45 | −1.49 | * | * | |
HILPDA | hypoxia inducible lipid droplet-associated | 29923 | 7.25e-05 | 9.73e-04 | 3.21e-03 | −1.20 | −1.01 | −2.09 | ** | ||
HIST1H2AK | histone cluster 1, H2ak | 8330 | 3.09e-03 | 2.95e-03 | 1.11e-01 | −1.05 | −1.71 | −1.85 | * | ** | |
HIST2H2BF | histone cluster 2, H2bf | 440689 | 4.80e-03 | 4.43e-05 | 6.62e-01 | 1.36 | 1.32 | 1.47 | ** | * | ** |
HIST2H4A | histone cluster 2, H4a | 8370 | 0.00e+00 | 4.91e-07 | 1.85e-02 | 1.87 | 1.46 | 1.32 | ** | ** | ** |
HK2 | hexokinase 2 | 3099 | 1.25e-06 | 4.59e-04 | 1.65e-03 | 1.06 | −1.37 | −2.25 | * | ** | |
HMMR | hyaluronan-mediated motility receptor (RHAMM) | 3161 | 1.23e-02 | 2.21e-01 | 8.49e-03 | 1.58 | −1.43 | −1.71 | * | * | |
HMOX1 | heme oxygenase (decycling) 1 | 3162 | 1.69e-02 | 3.20e-04 | 3.02e-01 | −1.51 | −1.19 | −1.41 | ** | ** | |
ID2 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein | 3398 | 5.45e-03 | 1.51e-04 | 1.15e-02 | 1.38 | 1.58 | 1.03 | ** | ** | |
IDI1 | isopentenyl-diphosphate delta isomerase 1 | 3422 | 6.89e-02 | 4.10e-03 | 2.47e-01 | 1.70 | 1.21 | 1.23 | ** | ||
IGFL1 | IGF-like family member 1 | 374918 | 0.00e+00 | 1.06e-05 | 8.05e-01 | −2.11 | −2.05 | −2.41 | ** | ** | ** |
IL1B | interleukin 1, beta | 3553 | 2.12e-03 | 1.50e-03 | 3.88e-01 | −1.29 | −1.92 | −1.69 | ** | * | |
IL32 | interleukin 32 | 9235 | 3.56e-03 | 8.70e-05 | 1.94e-01 | −1.23 | −1.34 | −1.59 | ** | ** | |
IL7R | interleukin 7 receptor | 3575 | 2.09e-04 | 7.60e-04 | 8.60e-02 | −1.11 | −1.95 | −1.69 | ** | ** | |
IRF2BP2 | interferon regulatory factor 2 binding protein 2 | 359948 | 1.26e-02 | 7.17e-02 | 2.00e-04 | −1.65 | 1.11 | 1.13 | ** | ||
ISCA1 | iron–sulfur cluster assembly 1 homolog (S. cerevisiae) | 81689 | 2.42e-02 | 2.41e-03 | 1.97e-01 | 1.60 | 1.54 | 1.10 | ** | * | |
ISG20L2 | interferon stimulated exonuclease gene 20 kDa-like 2 | 81875 | 8.45e-02 | 4.01e-02 | 2.40e-03 | −1.62 | 1.08 | 1.03 | ** | ||
KCTD11 | potassium channel tetramerisation domain containing 11 | 147040 | 4.26e-05 | 1.92e-04 | 3.55e-01 | −1.91 | −1.36 | −1.65 | ** | ** | |
KDELC1 | KDEL (Lys-Asp-Glu-Leu) containing 1 | 79070 | 5.23e-02 | 7.58e-05 | 3.32e-01 | 1.20 | 1.43 | 1.30 | ** | ** | |
KHDRBS3 | KH domain containing, RNA binding, signal transduction associated 3 | 10656 | 1.79e-03 | 2.61e-06 | 7.74e-04 | 1.05 | 1.57 | 1.32 | ** | ** | |
KIAA0922 | KIAA0922 | 23240 | 1.60e-02 | 1.12e-03 | 3.47e-01 | 1.25 | 1.68 | 1.35 | ** | ||
KIAA1524 | KIAA1524 | 57650 | 2.09e-02 | 3.06e-01 | 1.10e-02 | 1.64 | −1.68 | −1.44 | * | * | |
KIF14 | kinesin family member 14 | 9928 | 1.42e-02 | 8.55e-01 | 1.29e-02 | 2.46 | −1.70 | −1.31 | * | ||
KIF23 | kinesin family member 23 | 9493 | 7.31e-02 | 1.00e+00 | 1.64e-02 | 1.88 | −1.46 | −1.29 | * | ||
KLRAP1 | killer cell lectin-like receptor subfamily A pseudogene 1 | 10748 | 9.99e-02 | 9.35e-01 | 2.08e-02 | 1.86 | −1.58 | −1.22 | * | ||
KRT16 | keratin 16 | 3868 | 8.89e-04 | 7.06e-04 | 5.60e-01 | −1.73 | −1.76 | −1.37 | * | ** | |
KRT17 | keratin 17 | 3872 | 1.35e-03 | 6.95e-04 | 2.03e-01 | −1.86 | −1.24 | −1.43 | ** | * | |
KRT34 | keratin 34 | 3885 | 6.82e-02 | 5.18e-04 | 8.08e-01 | −1.27 | −1.37 | −1.40 | ** | ||
LAMB3 | laminin, beta 3 | 3914 | 9.31e-03 | 7.05e-04 | 8.37e-01 | −1.57 | −1.44 | −1.39 | ** | * | * |
LIF | leukemia inhibitory factor | 3976 | 1.04e-03 | 1.87e-02 | 1.93e-03 | −1.34 | 1.51 | 1.62 | * | ** | ** |
LMCD1 | LIM and cysteine-rich domains 1 | 29995 | 7.13e-02 | 2.87e-04 | 8.53e-01 | −1.38 | −1.33 | −1.28 | ** | ||
LOC100130713 | uncharacterized LOC100130713 | 100130713 | 8.73e-03 | 3.78e-02 | 1.06e-03 | −1.33 | 1.51 | 1.34 | * | ** | * |
LOC440896 | uncharacterized LOC440896 | 440896 | 1.04e-02 | 7.89e-04 | 8.40e-01 | −1.55 | −1.49 | −1.37 | * | * | |
LOX | lysyl oxidase | 4015 | 2.52e-02 | 2.34e-04 | 3.94e-02 | −1.15 | −1.19 | −1.60 | ** | ||
LPIN1 | lipin 1 | 23175 | 1.40e-03 | 2.40e-04 | 4.71e-02 | 1.72 | 1.37 | 1.12 | ** | * | |
MARCH8 | membrane-associated ring finger (C3HC4) 8, E3 ubiquitin protein ligase | 220972 | 7.20e-02 | 2.41e-03 | 2.60e-01 | 1.12 | 1.54 | 1.42 | ** | * | |
MEF2D | myocyte enhancer factor 2D | 4209 | 4.21e-03 | 9.11e-02 | 1.55e-03 | −1.84 | 1.24 | −1.00 | ** | ||
MEGF9 | multiple EGF-like-domains 9 | 1955 | 1.01e-04 | 2.69e-04 | 9.48e-01 | 1.62 | 1.76 | 1.69 | * | ** | * |
MERTK | c-mer proto-oncogene tyrosine kinase | 10461 | 6.83e-05 | 2.96e-05 | 6.07e-02 | 1.28 | 1.79 | 1.32 | * | ** | * |
MINPP1 | multiple inositol-polyphosphate phosphatase 1 | 9562 | 4.12e-02 | 2.07e-03 | 6.87e-01 | 1.51 | 1.54 | 1.28 | * | * | |
MIR29A | microRNA 29a | 407021 | 6.91e-05 | 9.06e-04 | 3.57e-01 | 1.59 | 1.74 | 2.69 | ** | ||
MKI67 | antigen identified by monoclonal antibody Ki-67 | 4288 | 2.28e-02 | 6.57e-01 | 1.27e-02 | 2.18 | −1.58 | −1.13 | ** | ||
MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 4312 | 1.40e-04 | 1.11e-03 | 3.61e-02 | −1.08 | −1.44 | −2.18 | * | ** | |
MMP10 | matrix metallopeptidase 10 (stromelysin 2) | 4319 | 5.96e-08 | 1.29e-04 | 1.54e-03 | −1.02 | −1.38 | −2.37 | * | ** | |
MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 4314 | 1.93e-05 | 1.63e-03 | 2.51e-02 | −1.01 | −1.63 | −2.57 | * | * | ** |
MOB3C | MOB kinase activator 3C | 148932 | 2.40e-02 | 1.54e-02 | 7.70e-03 | −1.78 | 1.01 | −1.02 | ** | ||
MYLIP | myosin regulatory light chain interacting protein | 29116 | 0.00e+00 | 9.67e-07 | 8.89e-05 | 2.84 | 1.52 | 1.12 | ** | ** | |
NAV3 | neuron navigator 3 | 89795 | 7.05e-02 | 6.46e-01 | 6.03e-03 | 1.55 | −1.42 | −1.24 | * | * | |
NCAPG | non-SMC condensin I complex, subunit G | 64151 | 8.61e-02 | 7.39e-01 | 1.66e-02 | 1.89 | −1.41 | −1.18 | * | ||
NEK2 | NIMA-related kinase 2 | 4751 | 5.47e-02 | 2.39e-01 | 7.63e-03 | 1.78 | −1.23 | −1.04 | ** | ||
NINJ1 | ninjurin 1 | 4814 | 6.07e-02 | 5.10e-03 | 8.39e-02 | −1.70 | −1.25 | −1.06 | ** | ||
NIPAL4 | NIPA-like domain containing 4 | 348938 | 4.83e-03 | 6.92e-04 | 3.07e-01 | −1.74 | −1.31 | −1.32 | ** | ||
NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 4929 | 2.09e-03 | 5.30e-01 | 1.08e-03 | −1.85 | 1.21 | 1.31 | ** | ||
NUAK2 | NUAK family, SNF1-like kinase, 2 | 81788 | 1.41e-02 | 3.76e-04 | 1.70e-01 | −1.60 | −1.19 | −1.30 | ** | * | |
NXF1 | nuclear RNA export factor 1 | 10482 | 1.95e-02 | 4.17e-04 | 7.68e-02 | 1.19 | 1.63 | 1.20 | ** | ||
OLFM2 | olfactomedin 2 | 93145 | 9.51e-02 | 4.42e-03 | 7.98e-02 | −1.65 | −1.13 | −1.14 | ** | ||
OSBPL11 | oxysterol binding protein-like 11 | 114885 | 9.51e-02 | 8.43e-03 | 4.90e-01 | 1.84 | 1.30 | 1.37 | * | ||
OXTR | oxytocin receptor | 5021 | 1.11e-03 | 9.51e-06 | 5.52e-03 | −1.10 | −1.62 | −1.32 | ** | ** | |
P4HA1 | prolyl 4-hydroxylase, alpha polypeptide I | 5033 | 1.04e-04 | 4.09e-01 | 3.61e-04 | 1.58 | −1.02 | −1.89 | ** | ** | |
PCF11 | PCF11, cleavage and polyadenylation factor subunit, homolog (S. cerevisiae) | 51585 | 2.42e-02 | 3.67e-02 | 3.25e-02 | 2.13 | −1.01 | 1.06 | ** | ||
PDGFB | platelet-derived growth factor beta polypeptide | 5155 | 2.00e-04 | 6.09e-04 | 9.34e-02 | −2.09 | −1.26 | −1.36 | ** | ||
PDK1 | pyruvate dehydrogenase kinase, isozyme 1 | 5163 | 1.91e-06 | 2.69e-02 | 4.56e-04 | 1.44 | −1.19 | −2.37 | * | ** | |
PDZK1IP1 | PDZK1 interacting protein 1 | 10158 | 3.32e-02 | 2.18e-03 | 6.99e-02 | −1.60 | −1.03 | −1.39 | ** | * | |
PER1 | period circadian clock 1 | 5187 | 1.43e-02 | 6.69e-02 | 3.66e-03 | −1.84 | 1.08 | 1.08 | ** | ||
PFKFB4 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 | 5210 | 0.00e+00 | 3.32e-04 | 6.63e-05 | −1.06 | 1.04 | −2.67 | ** | ||
PHLDA3 | pleckstrin homology-like domain, family A, member 3 | 23612 | 4.60e-02 | 7.89e-04 | 5.33e-01 | −1.52 | −1.27 | −1.31 | ** | * | |
PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 5295 | 2.59e-03 | 1.84e-02 | 2.19e-02 | 2.40 | 1.14 | −1.02 | ** | ||
PIK3R3 | phosphoinositide-3-kinase, regulatory subunit 3 (gamma) | 8503 | 1.86e-02 | 4.86e-04 | 5.59e-01 | 1.28 | 1.54 | 1.37 | ** | * | |
PLAT | plasminogen activator, tissue | 5327 | 3.74e-02 | 1.90e-02 | 1.06e-01 | −2.20 | −1.18 | −1.12 | ** | ||
PLCB4 | phospholipase C, beta 4 | 5332 | 7.45e-06 | 3.68e-02 | 2.37e-03 | 1.73 | −2.07 | −2.14 | * | ** | ** |
PLEKHG2 | pleckstrin homology domain containing, family G (with RhoGef domain) member 2 | 64857 | 3.71e-02 | 3.43e-03 | 7.01e-02 | −1.72 | −1.23 | −1.08 | ** | ||
PLEKHM1 | pleckstrin homology domain containing, family M (with RUN domain) member 1 | 9842 | 8.05e-02 | 9.03e-02 | 1.43e-02 | −1.28 | 1.65 | 1.26 | ** | ||
PLEKHM3 | pleckstrin homology domain containing, family M, member 3 | 389072 | 3.51e-02 | 4.36e-03 | 9.12e-01 | 1.57 | 1.78 | 1.56 | * | ||
PODXL | podocalyxin-like | 5420 | 1.55e-02 | 8.88e-04 | 9.91e-03 | −1.05 | −1.16 | −1.69 | ** | ||
POLA1 | polymerase (DNA directed), alpha 1, catalytic subunit | 5422 | 9.69e-02 | 3.40e-01 | 2.19e-02 | 1.95 | −1.35 | −1.00 | ** | ||
PPP1R18 | protein phosphatase 1, regulatory subunit 18 | 170954 | 2.09e-02 | 7.61e-03 | 1.02e-02 | −1.77 | −1.06 | −1.02 | ** | ||
PPP1R3C | protein phosphatase 1, regulatory subunit 3C | 5507 | 1.19e-02 | 9.34e-03 | 7.03e-02 | 1.04 | −1.54 | −1.94 | * | ** | |
PRDM1 | PR domain containing 1, with ZNF domain | 639 | 0.00e+00 | 1.29e-05 | 3.46e-06 | −2.47 | −1.04 | −1.01 | ** | ||
PRKCA | protein kinase C, alpha | 5578 | 3.16e-03 | 6.04e-04 | 9.57e-01 | 1.48 | 1.59 | 1.54 | * | * | * |
PRSS22 | protease, serine, 22 | 64063 | 2.23e-02 | 3.34e-04 | 8.39e-01 | −1.41 | −1.43 | −1.31 | ** | ** | |
PTCH1 | patched 1 | 5727 | 8.87e-02 | 1.19e-02 | 6.15e-03 | −1.02 | 1.65 | 1.04 | ** | ||
PTP4A3 | protein tyrosine phosphatase type IVA, member 3 | 11156 | 1.22e-04 | 2.90e-04 | 3.74e-01 | −1.51 | −1.95 | −1.41 | * | ** | |
PXDC1 | PX domain containing 1 | 221749 | 3.90e-02 | 3.71e-01 | 2.02e-03 | −1.66 | 1.16 | 1.19 | ** | ||
RAI14 | retinoic acid induced 14 | 26064 | 9.76e-02 | 7.26e-01 | 1.68e-02 | 1.87 | −1.31 | −1.26 | * | ||
RASD2 | RASD family, member 2 | 23551 | 6.21e-02 | 7.34e-04 | 2.19e-02 | −1.58 | −1.08 | −1.15 | ** | ||
RASSF5 | Ras association (RalGDS/AF-6) domain family member 5 | 83593 | 9.60e-02 | 2.47e-04 | 6.95e-01 | −1.29 | −1.39 | −1.25 | ** | ||
RIPK4 | receptor-interacting serine–threonine kinase 4 | 54101 | 1.33e-03 | 3.07e-04 | 1.37e-02 | −1.79 | −1.10 | −1.23 | ** | ||
RND1 | Rho family GTPase 1 | 27289 | 9.23e-03 | 1.56e-02 | 5.23e-02 | −1.12 | 1.59 | 2.06 | ** | ||
RNF103 | ring finger protein 103 | 7844 | 6.68e-02 | 2.52e-03 | 9.20e-01 | 1.44 | 1.51 | 1.37 | * | * | |
RRM2 | ribonucleotide reductase M2 | 6241 | 5.93e-02 | 3.12e-03 | 1.19e-02 | 1.59 | 1.22 | −1.04 | ** | ||
S100A3 | S100 calcium binding protein A3 | 6274 | 0.00e+00 | 7.47e-06 | 5.36e-02 | −2.37 | −1.37 | −2.05 | ** | ** | |
SAMD4A | sterile alpha motif domain containing 4A | 23034 | 7.19e-04 | 4.28e-06 | 7.70e-02 | 1.22 | 1.56 | 1.36 | * | ** | ** |
SELE | selectin E | 6401 | 2.45e-03 | 2.50e-03 | 1.08e-02 | −1.01 | 1.24 | 1.89 | ** | ||
SEMA4C | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C | 54910 | 9.90e-02 | 1.27e-03 | 8.89e-02 | −1.53 | −1.26 | −1.08 | ** | * | |
SERPINA3 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 | 12 | 2.93e-03 | 4.08e-03 | 1.68e-01 | −2.38 | −1.29 | −1.37 | ** | ||
SERPINB9 | serpin peptidase inhibitor, clade B (ovalbumin), member 9 | 5272 | 4.70e-02 | 4.96e-03 | 1.48e-01 | −1.07 | −1.39 | −1.72 | ** | ||
SERPINH1 | serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) | 871 | 6.23e-02 | 1.47e-03 | 4.28e-01 | −1.27 | −1.27 | −1.58 | ** | ||
SERPINI1 | serpin peptidase inhibitor, clade I (neuroserpin), member 1 | 5274 | 2.82e-02 | 1.25e-03 | 6.61e-01 | 1.54 | 1.28 | 1.46 | * | * | |
SLC2A1 | solute carrier family 2 (facilitated glucose transporter), member 1 | 6513 | 2.93e-03 | 1.28e-03 | 6.12e-02 | −1.23 | −1.19 | −1.91 | ** | ||
SLC33A1 | solute carrier family 33 (acetyl-CoA transporter), member 1 | 9197 | 6.24e-02 | 6.09e-04 | 3.29e-01 | 1.42 | 1.42 | 1.16 | ** | ** | |
SLC35D1 | solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1 | 23169 | 5.29e-02 | 3.06e-03 | 6.97e-01 | 1.65 | 1.38 | 1.35 | * | ||
SLC6A14 | solute carrier family 6 (amino acid transporter), member 14 | 11254 | 8.97e-02 | 5.67e-03 | 8.88e-02 | 1.01 | −1.46 | −1.50 | * | * | |
SLC6A8 | solute carrier family 6 (neurotransmitter transporter, creatine), member 8 | 6535 | 2.16e-03 | 1.14e-03 | 1.69e-02 | −1.03 | 1.70 | 1.47 | ** | ** | |
SMIM14 | small integral membrane protein 14 | 201895 | 7.25e-02 | 3.85e-03 | 4.08e-01 | 1.19 | 1.64 | 1.41 | * | ||
SNHG12 | small nucleolar RNA host gene 12 (non-protein coding) | 85028 | 2.55e-04 | 1.61e-05 | 6.39e-02 | 1.66 | 1.38 | 1.21 | ** | ** | * |
SNORA61 | small nucleolar RNA, H/ACA box 61 | 677838 | 7.99e-04 | 6.54e-05 | 7.40e-02 | 1.62 | 1.45 | 1.15 | ** | ** | |
SNORD105 | small nucleolar RNA, C/D box 105 | 692229 | 1.18e-02 | 5.73e-03 | 9.15e-02 | −1.82 | −1.58 | −1.00 | ** | * | |
SNORD13P2 | small nucleolar RNA, C/D box 13 pseudogene 2 | 6077 | 1.60e-02 | 8.33e-02 | 5.74e-03 | −1.88 | 1.16 | 1.01 | ** | ||
SNORD14E | small nucleolar RNA, C/D box 14E | 85391 | 1.44e-02 | 1.01e-02 | 9.15e-02 | 2.17 | 1.21 | 1.14 | ** | ||
SNORD22 | small nucleolar RNA, C/D box 22 | 9304 | 1.49e-06 | 3.21e-04 | 3.16e-02 | 2.57 | 1.32 | 1.34 | ** | ||
SNORD28 | small nucleolar RNA, C/D box 28 | 9300 | 4.12e-02 | 1.90e-03 | 1.47e-01 | 1.66 | 1.14 | 1.26 | ** | ||
SNORD30 | small nucleolar RNA, C/D box 30 | 9299 | 1.45e-02 | 3.29e-03 | 4.36e-02 | 1.82 | 1.11 | 1.16 | ** | ||
SNORD31 | small nucleolar RNA, C/D box 31 | 9298 | 5.13e-06 | 9.26e-05 | 3.20e-03 | 2.08 | 1.18 | 1.17 | ** | ||
SNORD32A | small nucleolar RNA, C/D box 32A | 26819 | 6.96e-02 | 1.74e-02 | 3.10e-02 | −1.66 | −1.32 | 1.11 | ** | ||
SPRY4 | sprouty homolog 4 (Drosophila) | 81848 | 8.04e-02 | 2.15e-03 | 1.03e-01 | −1.59 | −1.09 | −1.25 | ** | ||
SRGN | serglycin | 5552 | 1.96e-02 | 1.14e-04 | 7.38e-02 | −1.15 | −1.28 | −1.55 | * | ** | |
STAT5A | signal transducer and activator of transcription 5A | 6776 | 8.68e-02 | 6.33e-04 | 6.45e-01 | −1.22 | −1.38 | −1.40 | ** | ||
STC1 | stanniocalcin 1 | 6781 | 8.00e-04 | 1.62e-03 | 1.37e-02 | −1.21 | −1.06 | −2.01 | ** | ||
STC2 | stanniocalcin 2 | 8614 | 9.30e-04 | 1.85e-03 | 5.42e-03 | 1.01 | −1.19 | −1.93 | ** | ||
STK17B | serine/threonine kinase 17b | 9262 | 1.23e-03 | 1.93e-03 | 1.18e-01 | 2.15 | 1.36 | 1.23 | ** | ||
STX4 | syntaxin 4 | 6810 | 2.28e-03 | 1.23e-04 | 9.23e-01 | −1.49 | −1.40 | −1.43 | ** | * | ** |
SYDE1 | synapse defective 1, Rho GTPase, homolog 1 (C. elegans) | 85360 | 9.00e-02 | 9.80e-04 | 4.81e-01 | −1.43 | −1.19 | −1.40 | ** | * | |
TAGLN | transgelin | 6876 | 3.45e-03 | 3.65e-04 | 6.89e-01 | −1.43 | −1.37 | −1.61 | * | * | ** |
TAS2R4 | taste receptor, type 2, member 4 | 50832 | 9.62e-02 | 1.10e-02 | 1.86e-01 | 1.83 | 1.15 | 1.22 | ** | ||
TFRC | transferrin receptor (p90, CD71) | 7037 | 7.32e-02 | 3.99e-01 | 2.32e-02 | 2.18 | −1.21 | −1.23 | ** | ||
TGFB1I1 | transforming growth factor beta 1 induced transcript 1 | 7041 | 8.92e-05 | 2.58e-05 | 9.24e-01 | −1.47 | −1.48 | −1.55 | ** | ** | ** |
TGFB2 | transforming growth factor, beta 2 | 7042 | 1.50e-05 | 2.51e-03 | 3.22e-03 | 1.19 | −2.14 | −1.52 | ** | * | |
TICAM1 | toll-like receptor adaptor molecule 1 | 148022 | 4.13e-03 | 8.38e-03 | 8.32e-04 | −1.79 | 1.05 | 1.01 | ** | ||
TLE1 | transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) | 7088 | 3.37e-03 | 1.25e-02 | 3.72e-04 | −1.23 | 1.70 | 1.14 | * | ** | |
TM4SF18 | transmembrane 4L six family member 18 | 116441 | 3.05e-02 | 6.72e-02 | 2.10e-03 | 1.31 | −1.24 | −1.55 | * | ** | |
TMEM2 | transmembrane protein 2 | 23670 | 2.67e-02 | 5.08e-03 | 6.27e-01 | 2.00 | 1.44 | 1.53 | * | ||
TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 7130 | 1.27e-02 | 4.06e-03 | 2.87e-01 | −1.16 | −1.70 | −1.84 | * | * | |
TNFRSF11B | tumor necrosis factor receptor superfamily, member 11b | 4982 | 6.74e-06 | 4.09e-04 | 2.27e-01 | −1.49 | −2.62 | −1.70 | ** | * | |
TNFSF18 | tumor necrosis factor (ligand) superfamily, member 18 | 8995 | 0.00e+00 | 3.06e-06 | 3.10e-01 | −2.41 | −4.24 | −3.41 | ** | ** | ** |
TOP2A | topoisomerase (DNA) II alpha 170 kDa | 7153 | 4.62e-02 | 8.29e-01 | 1.18e-02 | 1.90 | −1.42 | −1.24 | ** | ||
TRAF1 | TNF receptor-associated factor 1 | 7185 | 2.49e-04 | 8.97e-05 | 2.32e-01 | −1.69 | −1.50 | −1.26 | ** | ** | |
TRIP6 | thyroid hormone receptor interactor 6 | 7205 | 8.37e-02 | 9.63e-04 | 6.24e-01 | −1.48 | −1.30 | −1.26 | ** | * | |
TSGA10 | testis specific, 10 | 80705 | 6.19e-02 | 6.67e-03 | 1.65e-02 | 1.68 | 1.07 | 1.04 | ** | ||
TTLL3 | tubulin tyrosine ligase-like family, member 3 | 26140 | 3.38e-03 | 1.07e-03 | 1.29e-02 | −1.04 | 1.65 | 1.45 | ** | ** | |
UBALD1 | UBA-like domain containing 1 | 124402 | 1.29e-02 | 9.81e-02 | 5.00e-03 | −1.88 | 1.23 | −1.03 | ** | ||
ULBP3 | UL16 binding protein 3 | 79465 | 5.51e-02 | 3.20e-04 | 1.21e-01 | 1.30 | 1.50 | 1.12 | * | ** | |
ULK1 | unc-51-like kinase 1 (C. elegans) | 8408 | 8.48e-02 | 4.11e-01 | 2.45e-03 | −1.44 | 1.33 | 1.27 | ** | * | |
USP38 | ubiquitin specific peptidase 38 | 84640 | 8.54e-03 | 1.46e-04 | 4.15e-01 | 1.53 | 1.34 | 1.27 | ** | * | * |
VAMP1 | vesicle-associated membrane protein 1 (synaptobrevin 1) | 6843 | 1.08e-03 | 3.77e-05 | 4.65e-01 | 1.49 | 1.48 | 1.28 | ** | ** | * |
VLDLR | very low density lipoprotein receptor | 7436 | 4.04e-02 | 4.49e-04 | 2.18e-03 | −1.05 | −1.08 | −1.61 | ** | ||
ZC3H7B | zinc finger CCCH-type containing 7B | 23264 | 6.99e-02 | 4.01e-04 | 8.97e-01 | −1.39 | −1.30 | −1.32 | ** | ||
ZC3HAV1 | zinc finger CCCH-type, antiviral 1 | 56829 | 4.54e-02 | 3.89e-03 | 2.25e-01 | 1.74 | 1.29 | 1.17 | ** | ||
ZCCHC14 | zinc finger, CCHC domain containing 14 | 23174 | 3.05e-02 | 1.36e-03 | 9.05e-02 | 1.11 | 1.66 | 1.27 | ** | ||
ZNF253 | zinc finger protein 253 | 56242 | 5.52e-02 | 2.43e-02 | 1.07e-01 | 2.18 | 1.16 | 1.11 | ** | ||
ZNF426 | zinc finger protein 426 | 79088 | 6.98e-02 | 3.42e-03 | 7.62e-01 | 1.55 | 1.51 | 1.30 | * | * | |
ZNF48 | zinc finger protein 48 | 197407 | 5.05e-02 | 5.04e-03 | 1.14e-02 | −1.67 | −1.07 | −1.03 | ** | ||
ZNF487P | zinc finger protein 487, pseudogene | 642819 | 5.33e-05 | 1.01e-03 | 5.62e-02 | 1.47 | 2.43 | 1.18 | ** | ||
ZNF724P | zinc finger protein 724, pseudogene | 440519 | 3.69e-02 | 1.45e-01 | 1.73e-02 | 2.07 | −1.05 | −1.15 | ** | ||
ZNF737 | zinc finger protein 737 | 100129842 | 2.08e-02 | 6.03e-03 | 3.48e-01 | 2.11 | 1.29 | 1.46 | ** | ||
ZSWIM6 | zinc finger, SWIM-type containing 6 | 57688 | 4.63e-02 | 5.34e-03 | 4.44e-01 | 1.55 | 1.78 | 1.22 | * |
P-values in bold if significant at two-factor ANOVA (<0.05).
FDR: false discovery rate, according to BETR analysis. Ptreatment: P-value for treatment effect; and Pinteraction: P-value for interaction effect, at two-factor ANOVA. FC: fold-change in Aminaphtone-treated vs. untreated IL-1β-stimulated endothelial cells. AMNA: Aminaphtone. Pairwise: pairwise significant at two-tailed t-test.
P<0.05.
P<0.01 at two-tailed t-test.